H.pylori vaccines + Placebo Vaccine
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Helicobacter Pylori Infection
Conditions
Helicobacter Pylori Infection
Trial Timeline
Oct 1, 2008 → Apr 1, 2010
NCT ID
NCT00736476About H.pylori vaccines + Placebo Vaccine
H.pylori vaccines + Placebo Vaccine is a phase 1 stage product being developed by Novartis for Helicobacter Pylori Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00736476. Target conditions include Helicobacter Pylori Infection.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00736476 | Phase 1 | Completed |
Competing Products
6 competing products in Helicobacter Pylori Infection
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy | Sun Pharmaceutical | Approved | 85 |
| Rabeprazole Sodium | Eisai | Pre-clinical | 23 |
| helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine | Novartis | Phase 1 | 33 |
| Vonoprazan + Amoxicillin + Clarithromycin + Lansoprazole | Phathom Pharmaceuticals | Phase 3 | 72 |
| pantoprazole + bismuth + metronidazole + tetracycline | Pacific Biosciences | Approved | 77 |
| RHB-105 + Active Comparator | RedHill Biopharma | Phase 3 | 69 |